Nadav Kidron - President and CEO, Director at Oramed Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ORMP on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nadav Kidron since 10/7/2024

Holdings reported by Nadav Kidron for Oramed Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.69M $5.94M $2.21 Feb 11, 2025 Direct
Common Stock 126K $278K $2.21 Feb 11, 2025 By wholly-owned corporation

Transactions reported by Nadav Kidron for Oramed Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.